Previous 10 | Next 10 |
Q BioMed Announces Initial $500k Order of Strontium89 to Chinese Market Order Represents a small fraction of the overall market PR Newswire NEW YORK , March 7, 2022 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced...
Q BioMed Outlines Strategic Direction for 2022 Revenue Grows, Monetization Focus PR Newswire NEW YORK , Feb. 14, 2022 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biomedical acceleration and development company, focused on licensing, acquiring,...
Q BioMed Shows Significant Uptrend in Revenues in Year-End Update Revenue up 600% in 2021 and 100% in Q4 Nasdaq Listing Expected in Jan 2022 PR Newswire NEW YORK , Dec. 16, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ), a commercia...
Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership Fully integrated commercialization model and newly appointed leadership to accelerate U.S. business PR Newswire NEW YORK and CHICAGO, Nov. 8, 2021 /PRNewswire/ -- Q BioMed I...
Q BioMed Inc. Provides Shareholder Update $2M Raised with focus on sales and licensing revenue pipeline and Uplisting to Nasdaq PR Newswire NEW YORK , Oct. 25, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biotech acceleration and comm...
Q BioMed Inc. Provides Update on Strontium89 Commercial Roll Out Revenue Up in 4th Quarter with Positive Trend PR Newswire NEW YORK , Sept. 28, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ) a biotech acceleration and commercial stage company focus...
Palm Beach, FL – September 22, 2021 – FinancialNewsMedia.com News Commentary – The U.S. government, via the American Rescue Plan, is investing more than $3 billion to accelerate the discovery, development and manufacturing of antiviral medicines as part of t...
Q BioMed Inc. Updates on COVID-19 Therapeutic Development and Clinical Trials - MAN-19 therapeutic program heading to clinical trial in early 2022 PR Newswire NEW YORK , Sept. 22, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a commercial sta...
Palm Beach, FL – August 24, 2021 – FinancialNewsMedia.com News Commentary – Recently, approximately 1.2 million new liver cancer cases have been reporting around the world. The increasing intense research and development activities opposing dangerous disease...
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent in South Korea and Shows Promising Results in Initial Pre-Clinical Testing PR Newswire NEW YORK , Aug. 24, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech ...
News, Short Squeeze, Breakout and More Instantly...
Veradigm Inc. (MDRX) is expected to report $0.17 for Q3 2023 Aperam SA New York Shares (APEMY) is expected to report for Q3 2023 HTG Molecular Diagnostics Inc. (HTGMQ) is expected to report for Q3 2023 Enel Spa ADR (ENLAY) is expected to report for Q3 2023 Firm Capital Property Tr...
Impac Mortgage Holdings, Inc. (IMPM) is expected to report for quarter end 2023-09-30 Westbury Bancorp Inc (WBBW) is expected to report for quarter end 2023-09-30 Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.24 for Q3 2023 Zalando SE ADR (ZLNDY) is expected to report for...
thyssenkrupp AG (TYEKF) is expected to report for Q4 2023 Azul S.A. American Depositary Shares (each representing three preferred shares) (AZUL) is expected to report $-0.38 for Q3 2023 Bath & Body Works Inc. (BBWI) is expected to report $0.36 for Q3 2024 Johnson Controls Internat...